Zystus Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-12-2024
- Paid Up Capital ₹ 7.10 M
as on 06-12-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -84.83%
(FY 2022)
- Profit -132.86%
(FY 2022)
- Ebitda -96.48%
(FY 2022)
- Net Worth -2.29%
(FY 2022)
- Total Assets -9.70%
(FY 2022)
About Zystus Nutraceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amar Venkatarangan and Deepa Subramanian serve as directors at the Company.
- CIN/LLPIN
U73100TG2018PTC127825
- Company No.
127825
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zystus Nutraceuticals Private Limited offer?
Zystus Nutraceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Immunity Booster, Ayurvedic Medicine.
Who are the key members and board of directors at Zystus Nutraceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amar Venkatarangan  | Director | 23-Oct-2018 | Current |
| Deepa Subramanian | Director | 22-Jan-2021 | Current |
Financial Performance of Zystus Nutraceuticals.
Zystus Nutraceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 84.83% decrease. The company also saw a substantial fall in profitability, with a 132.86% decrease in profit. The company's net worth dipped by a decrease of 2.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zystus Nutraceuticals?
In 2021, Zystus Nutraceuticals had a promoter holding of 99.53% and a public holding of 0.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zystus Nutraceuticals?
Unlock and access historical data on people associated with Zystus Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zystus Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zystus Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
